Latest Insider Transactions at Arcutis Biotherapeutics, Inc. (ARQT)

ARQT Quotes by TradingView

This section provides a real-time view of insider transactions for Arcutis Biotherapeutics, Inc. (ARQT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Arcutis Biotherapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Arcutis Biotherapeutics, Inc.'s insiders and make more informed investment decisions.

Insider Transaction List

Date Insider Transaction Ownership Type Shares Traded Value / Price
Apr 02 2025
David Joseph Topper Chief Financial Officer
SELL
Open market or private sale
Direct
9,600 -4.99%
$144,000 $15.8 P/Share
Apr 01 2025
Howard G. Welgus Director
SELL
Open market or private sale
Direct
10,000 -7.58%
$150,000 $15.12 P/Share
Mar 25 2025
Todd Franklin Watanabe Director
SELL
Open market or private sale
Direct
2,171 -0.23%
$36,907 $17.56 P/Share
Mar 24 2025
Todd Franklin Watanabe Director
SELL
Open market or private sale
Direct
1,500 -0.16%
$25,500 $17.52 P/Share
Mar 17 2025
Todd Franklin Watanabe Director
SELL
Open market or private sale
Direct
1,200 -0.13%
$20,400 $17.61 P/Share
Mar 14 2025
Patrick Burnett Officer
SELL
Open market or private sale
Direct
12,242 -9.12%
$183,630 $15.04 P/Share
Mar 14 2025
Patrick Burnett Officer
BUY
Exercise of conversion of derivative security
Direct
12,242 +8.36%
-
Mar 13 2025
Patrick Burnett Officer
SELL
Open market or private sale
Direct
49,161 -15.26%
$737,415 $15.04 P/Share
Mar 13 2025
Patrick Burnett Officer
BUY
Exercise of conversion of derivative security
Direct
5,008 +3.8%
-
Mar 04 2025
Todd Franklin Watanabe Director
SELL
Open market or private sale
Direct
4,135 -0.44%
$53,755 $13.28 P/Share
Mar 03 2025
Masaru Matsuda Officer
SELL
Open market or private sale
Direct
3,263 -1.53%
$42,419 $13.03 P/Share
Mar 03 2025
Howard G. Welgus Director
SELL
Open market or private sale
Direct
10,000 -7.05%
$130,000 $13.0 P/Share
Mar 03 2025
Todd Franklin Watanabe Director
SELL
Open market or private sale
Direct
20,880 -2.19%
$271,440 $13.03 P/Share
Mar 03 2025
Patrick Burnett Officer
SELL
Open market or private sale
Direct
2,819 -1.66%
$36,647 $13.03 P/Share
Feb 28 2025
Masaru Matsuda Officer
BUY
Grant, award, or other acquisition
Direct
34,000 +13.78%
-
Feb 28 2025
Larry Todd Edwards Officer
BUY
Grant, award, or other acquisition
Direct
55,000 +13.08%
-
Feb 28 2025
David Joseph Topper Chief Financial Officer
BUY
Grant, award, or other acquisition
Direct
34,000 +15.02%
-
Feb 28 2025
Todd Franklin Watanabe Director
BUY
Grant, award, or other acquisition
Direct
151,000 +13.65%
-
Feb 28 2025
Patrick Burnett Officer
BUY
Grant, award, or other acquisition
Direct
55,000 +14.5%
-
Feb 03 2025
Larry Todd Edwards Officer
SELL
Open market or private sale
Direct
2,173 -1.58%
$26,076 $12.7 P/Share
Feb 03 2025
Patrick Burnett Officer
SELL
Open market or private sale
Direct
12,116 -9.54%
$145,392 $12.7 P/Share
Feb 03 2025
Howard G. Welgus Director
SELL
Open market or private sale
Direct
10,000 -6.58%
$120,000 $12.71 P/Share
Feb 03 2025
Todd Franklin Watanabe Director
SELL
Open market or private sale
Direct
19,301 -2.34%
$231,612 $12.7 P/Share
Feb 03 2025
Masaru Matsuda Officer
SELL
Open market or private sale
Direct
8,338 -4.46%
$100,056 $12.7 P/Share
Jan 02 2025
Howard G. Welgus Director
SELL
Open market or private sale
Direct
10,000 -6.18%
$140,000 $14.67 P/Share
Dec 31 2024
Patrick Burnett Officer
SELL
Open market or private sale
Direct
1,691 -1.31%
$23,674 $14.0 P/Share
Dec 20 2024
Todd Franklin Watanabe Director
SELL
Open market or private sale
Direct
15,000 -1.79%
$225,000 $15.17 P/Share
Dec 02 2024
Howard G. Welgus Director
SELL
Open market or private sale
Direct
10,000 -5.82%
$120,000 $12.51 P/Share
Nov 30 2024
Todd Franklin Watanabe Director
BUY
Open market or private purchase
Direct
2,038 +0.24%
$14,266 $7.11 P/Share
Nov 30 2024
Masaru Matsuda Officer
BUY
Open market or private purchase
Direct
1,657 +0.88%
$11,599 $7.11 P/Share
Nov 30 2024
Larry Todd Edwards Officer
BUY
Open market or private purchase
Direct
1,093 +0.79%
$7,651 $7.11 P/Share
Nov 22 2024
Patrick Burnett Officer
SELL
Open market or private sale
Direct
16,023 -11.07%
$160,230 $10.14 P/Share
Nov 22 2024
Patrick Burnett Officer
BUY
Exercise of conversion of derivative security
Direct
16,023 +9.97%
-
Nov 19 2024
Masaru Matsuda Officer
SELL
Open market or private sale
Direct
1,775 -0.97%
$15,975 $9.68 P/Share
Nov 18 2024
Masaru Matsuda Officer
BUY
Grant, award, or other acquisition
Direct
4,875 +2.59%
-
Nov 15 2024
Patrick Burnett Officer
SELL
Open market or private sale
Direct
100 -0.08%
$1,000 $10.03 P/Share
Nov 15 2024
Patrick Burnett Officer
BUY
Exercise of conversion of derivative security
Direct
100 +0.08%
-
Nov 14 2024
Patrick Burnett Officer
SELL
Open market or private sale
Direct
69,126 -20.39%
$691,260 $10.29 P/Share
Nov 14 2024
Patrick Burnett Officer
BUY
Exercise of conversion of derivative security
Direct
18,377 +11.11%
-
Nov 11 2024
Terrie Curran Director
SELL
Open market or private sale
Direct
8,687 -46.14%
$86,870 $10.85 P/Share
Nov 04 2024
Patrick Burnett Officer
SELL
Open market or private sale
Direct
15,441 -7.92%
$123,528 $8.68 P/Share
Nov 04 2024
Todd Franklin Watanabe Director
SELL
Open market or private sale
Direct
13,871 -1.64%
$110,968 $8.68 P/Share
Nov 04 2024
Masaru Matsuda Officer
SELL
Open market or private sale
Direct
5,015 -2.74%
$40,120 $8.68 P/Share
Nov 01 2024
Howard G. Welgus Director
SELL
Open market or private sale
Direct
10,000 -5.5%
$80,000 $8.65 P/Share
Oct 02 2024
Larry Todd Edwards Officer
SELL
Open market or private sale
Direct
3,725 -2.65%
$37,250 $10.01 P/Share
Oct 01 2024
Howard G. Welgus Director
SELL
Open market or private sale
Direct
10,000 -5.21%
$90,000 $9.26 P/Share
Sep 24 2024
David Joseph Topper Chief Financial Officer
SELL
Open market or private sale
Direct
11,626 -6.84%
$104,634 $9.48 P/Share
Sep 21 2024
David Joseph Topper Chief Financial Officer
BUY
Grant, award, or other acquisition
Direct
60,000 +26.09%
-
Sep 03 2024
Howard G. Welgus Director
SELL
Open market or private sale
Direct
10,000 -4.95%
$100,000 $10.77 P/Share

Track Institutional and Insider Activities on ARQT

Follow Arcutis Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARQT shares.

Notify only if
Any

Insider Trading

Get notified when an Arcutis Biotherapeutics, Inc. insider buys or sells ARQT shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Arcutis Biotherapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ARQT